5 -Training and educational capacity to build competencies
|
Quality
Management |
Training and
Education |
Public
Involvement |
| Description | ||
|---|---|---|
Name |
ITCC - Innovative Therapies for Children and Adolescents with Cancer |
|
| Evidence of collaboration with regulatory authorities | Yes | - ITCC members contributed to the Paediatric Addendum of the EMA guidance for the development of anticancer drugs in human (CPMP/EWP/569/02 July 2003) - ITCC collaborates closely with EMA both directly and through Accelerate activities for example the 'Paediatric Strategy Forums'; ITCC is a founder member of Accelerate |
| Capacity to provide competent consultation to regulatory authorities | Yes | ITCC has the expertise in all fields of paediatric oncology and haematology to provide competent consultation to regulatory authorities. |
| Formal meetings for clinical trials | Yes | - for each clinical trial, an investigator meeting is being held at least once a year. - the tumour committees have visioconference calls on a monthly basis to manage ITCC trials portfolio - one General Assembly meeting is held each year. |
| Training courses given over the last 2 years | Yes | ITCC has an Education & Training Committee which coordinates education activities including appointment of clinical fellows and collaboration on European training courses in paediatric oncology as well as organising bi-annual ITCC Training Days alternating with bi-annual ITCC Scientific Days. |
| Training courses received over the last 2 years | Yes | ITCC host an Annual Meeting which includes external speakers reporting on clinical trials and childhood external investigator meetings can he held alongside. |
| Promotion of participation in clinical trials in countries with limited resources | No | |
| List of Countries |